PharVision Advisers’s Brookdale Senior Living BKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,112
Closed -$152K 159
2025
Q4
$152K Buy
+14,112
New +$139K 0.08% 610

Other funds holding BKD

PharVision Advisers's BKD Position: Q1 2026 in Review

PharVision Advisers sold out of Brookdale Senior Living (BKD) in Q1 2026, closing a stake of 14,112 shares — an estimated $152K sold.

PharVision Advisers first reported a position in BKD in Q4 2025 and held it in 1 quarter. The position peaked at $152K in Q4 2025. 282 funds tracked by Wall St. Rank hold BKD as of Q1 2026.

  • PharVision Advisers reported no remaining Brookdale Senior Living position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,112 Brookdale Senior Living shares in Q1 2026, an estimated $152K.
  • PharVision Advisers first reported a position in Brookdale Senior Living in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Brookdale Senior Living position peaked at $152K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Brookdale Senior Living as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.